(Q33649211)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

main subject

placebo

0 references

multiple system atrophy

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

William Cheshire

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Steven Vernino

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

14

William D Dupont

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

8

Susan Perlman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Phillip A Low

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

David Robertson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Sid Gilman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Wolfgang Singer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Italo Biaggioni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Roy Freeman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Stephanie Lessig

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jay Mandrekar

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Thomas Chelimsky

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Wendy R Galpern

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Robert A Hauser

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

5 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

268-275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

The many faces of α-synuclein: from structure and toxicity to therapeutic target

7 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

α-Synuclein oligomers and clinical implications for Parkinson disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

"Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy: Cl vs N Phys Trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

A randomized clinical trial of lithium in multiple system atrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

A randomized trial of mesenchymal stem cells in multiple system atrophy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Multiple system atrophy: a clinical and neuropathological perspective

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Multiple system atrophy: an update.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Second consensus statement on the diagnosis of multiple system atrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Multiple system atrophy: alpha-synuclein and neuronal degeneration

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Cellular pathology in multiple system atrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Rifampicin attenuates brain damage in focal ischemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Transgenic models of alpha-synuclein pathology: past, present, and future

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Penetration of rifampicin into the brain tissue and cerebral extracellular space of rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Potential outcome measures and trial design issues for multiple system atrophy

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Paroxetine treatment improves motor symptoms in patients with multiple system atrophy.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Placebo-controlled trial of amantadine in multiple-system atrophy.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

New hope for mechanism-based treatment of Parkinson's disease

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Occupational therapy in multiple system atrophy: a pilot randomized controlled trial.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4030757

Targeting alpha-synuclein in Parkinson's disease

30 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970301-6

7 January 2021

Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970301-6

7 January 2021

Placebo-controlled trial of riluzole in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970301-6

7 January 2021

Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970301-6

7 January 2021

Rifampin and Red Urine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24507091

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/S1474-4422(13)70301-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24507091%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

PubMed publication ID

24507091

1 reference